Company Profiles

driven by the PitchBook Platform

Ability Pharmaceuticals

Description

Operator of a biopharmaceutical company intended to investigate cancer drugs inducing autophagy through the over expression of TRIB3 and the inhibiton of the PI3K/Akt/mTOR pathway. The company's biopharmaceutical process focuses on developing first-in-class causing autophagy molecules by the overexpression of Tribbles pseudokinase 3 (TRIB3), enabling doctors to treat multiple aggressive cancers.

2009

Founded

PRIVATE

Status

1-10

Employees

Grant

Latest Deal Type

$1.61M

Latest Deal Amount

$10.1M

Total Amount Raised

Description

Operator of a biopharmaceutical company intended to investigate cancer drugs inducing autophagy through the over expression of TRIB3 and the inhibiton of the PI3K/Akt/mTOR pathway. The company's biopharmaceutical process focuses on developing first-in-class causing autophagy molecules by the overexpression of Tribbles pseudokinase 3 (TRIB3), enabling doctors to treat multiple aggressive cancers.

Website:

www.abilitypharma.com

Formerly Known As

AB-Therapeutics

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery
Pharmaceuticals

Primary Office

Avenue Technology Park, 3 Center for New Technologies Business Technology Park Vallès, Cerdanyola 08290 BarcelonaSpain +34 93 586 8977
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Ability Pharmaceuticals's full profile, request a free trial.

Ability Pharmaceuticals Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Ability Pharmaceuticals Investors (3)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Government of SpainGovernment000 0000000 0000
Individual InvestorAngel (individual)Minority000 0000000 0000
Inveready Technology Investment GroupVenture CapitalMinority000 0000000 0000
Government of Spain Government
Individual Investor Angel (individual)
Inveready Technology Investment Group Venture Capital

Ability Pharmaceuticals Executive Team (7)

NameTitleBoard
Seat
Contact
Info
Jordi Espadaler Ph.DCo-Founder & Senior Advisor
Carles Domènech Ph.DCo-Founder, Chief Executive Officer & Board Member
Marc Cortal MDDirector, Clinical Research
Gemma FierroVice President, Clinical & Regulatory Affairs
Vanessa RuzVice President, Finance and Administration
Jordi Espadaler Ph.D Co-Founder & Senior Advisor
Carles Domènech Ph.D Co-Founder, Chief Executive Officer & Board Member
Marc Cortal MD Director, Clinical Research
Gemma Fierro Vice President, Clinical & Regulatory Affairs
Vanessa Ruz Vice President, Finance and Administration

Ability Pharmaceuticals Board Members (7)

NameRepresentingRoleSinceContact
Info
Carles Domènech Ph.DAbility PharmaceuticalsCo-Founder, Chief Executive Officer & Board Member000 0000
José Manuel ValadésSelfBoard Member000 0000
Josep Maria EcharriInveready Technology Investment GroupFounding Partner, Managing Partner & Chief Executive Officer000 0000
Luis Sánchez-LafuenteSelfChairman000 0000
Miquel BonacheraSelfVice Chairman000 0000
Carles Domènech Ph.D Co-Founder, Chief Executive Officer & Board Member Ability Pharmaceuticals
José Manuel Valadés Board Member Self
Josep Maria Echarri Founding Partner, Managing Partner & Chief Executive Officer Inveready Technology Investment Group
Luis Sánchez-Lafuente Chairman Self
Miquel Bonachera Vice Chairman Self
Request full access to PitchBook